VISTA Is a Diagnostic Biomarker and Immunotherapy Target of Aggressive Feline Mammary Carcinoma Subtypes
Feline mammary carcinoma (FMC) is a common neoplasia, showing aggressive clinicopathological features, without viable therapeutic options. The study of tumor microenvironment has gained importance, due to the ability to control tumor progression by regulating the immune response. Considering the lac...
Enregistré dans:
Auteurs principaux: | Andreia Gameiro, Catarina Nascimento, Jorge Correia, Fernando Ferreira |
---|---|
Format: | article |
Langue: | EN |
Publié: |
MDPI AG
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/fec4dc2818084f3cb9675c0ea2d4dd4f |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Journal of mammary gland biology and neoplasia
Publié: (1996) -
Treatment of natural mammary gland tumors in canines and felines using gold nanorods-assisted plasmonic photothermal therapy to induce tumor apoptosis
par: Ali MRK, et autres
Publié: (2016) -
Editorial: Immunotherapy as an Evolving Approach for the Treatment of Breast Cancer
par: Mai F. Tolba, et autres
Publié: (2021) -
Immunotherapy for HER2-positive breast cancer: recent advances and combination therapeutic approaches
par: Ayoub NM, et autres
Publié: (2019) -
POstmastectomy radioThErapy in Node-posiTive breast cancer with or without Internal mAmmary nodaL irradiation (POTENTIAL): a study protocol for a multicenter prospective phase III randomized controlled trial
par: Xu-Ran Zhao, et autres
Publié: (2021)